Immune evasion after SARS-CoV-2 Omicron BA.5 and XBB.1.9 endemic observed from Guangdong Province, China from 2022 to 2023
The cross-protection provided by NAbs induced by prototype and Omicron BA.5 variants was limited when challenged by BQ.1, XBB.1.1, XBB.1.9, XBB.1.16 and EG.5 variants. This indicates that we should pay more attention to the risk of multiple infection from any novel Omicron variants that may emerge in the near future.
Authors
- Jianfeng He (ORCID: https://orcid.org/0000-0001-8136-2692)
- Runyu Yuan (ORCID: https://orcid.org/0009-0000-9935-2839)
- Lilian Zeng
- Jiufeng Sun (ORCID: https://orcid.org/0000-0003-1047-929X)
- Baisheng Li (ORCID: https://orcid.org/0000-0003-1842-316X)
- Chumin Liang
- Lirong Zou (ORCID: https://orcid.org/0000-0003-2231-6906)
- Jing Lu
- Huan Zhang (ORCID: https://orcid.org/0009-0009-1420-0154)
- Zhe Liu (ORCID: https://orcid.org/0000-0001-5796-4335)
- Huifang Lin
- Pingping Zhou (ORCID: https://orcid.org/0000-0002-5740-3113)
- Lina Yi (ORCID: https://orcid.org/0000-0003-1122-6999)
- Xue Zhuang
Institutions
- Sun Yat-sen University (CN)
- Jinan University (CN)
- Guangdong Pharmaceutical University (CN)
- Guangdong Provincial Center for Disease Control and Prevention (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Virology Journal
- Published
- 2024-11-20
- DOI
- https://doi.org/10.1186/s12985-024-02573-x
- Citations
- 2
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.78